Skip to main content
. 2022 Nov 8;26:100554. doi: 10.1016/j.bbih.2022.100554

Table 1.

Anti-inflammatory properties of alternative antidepressant treatments.

Drug Classification Mood/Affect Inflammation Sources
Ketamine/NMDA receptor antagonists - rapid onset (30 min) of antidepressant effects, especially in treatment resistant depression
- decreased rumination, depressive behaviors, and depression scores
- Antidepressant effects persist for up to 7 days
- Decreased pro-inflammatory cytokines (i.e., TNF-α) that are correlated with decreased depression HumanAnimal
Cannabis/Cannabinoid - THC, CBD, and HU-580 show antidepressant-like effects in rodent behavioral tests
- UCS decreases eCB signalling
- FAAH enzyme inhibition leads to anti-depressant effects
- Decreased inflammatory cytokines (e.g., IL-6, TNF-α, IFN-ß)
- Decreased PGE2, COX activity, oxygen-derived free radicals, and nitric oxide
- Chronic stress induces inflammation which is rescued by cannabinoid treatment
HumanAnimal
Psychedelics - Decreased stress and anxiety-related behaviors
- Rapid and long-term antidepressant effects in MDD lasting up to 6 months
- Decreased CRP that correlates with decreased depression
- 5-MeO-DsMT increased cortisol and decreased IL-6
HumanAnimal

Note: Acronyms: UCS – unpredictable chronic stress, eCB – endocannabinoids, FAAH - Fatty acid amide hydrolase, TNF-α - Tumor necrosis factor alpha, IFN-ß – Tumor necrosis factor beta, PGE2 - Prostaglandin E2, COX – cyclooxygenase, CRP – C-reactive protein, 5-MeO-DMT - 5-methoxy-N,N-dimethyltryptamine, IL-6 – Interleukin-6, HU-580 – cannabidiolic acid methyl ester, MDD – major depressive disorder.